Syneos Health Inc. represents a commitment to healthcare innovation and collaboration. As a top global biopharmaceutical solutions organization, the company prioritizes the values of integrity, accountability, and agility. With a focus on delivering end-to-end solutions to clients, Syneos Health strives to accelerate the development of breakthrough therapies. The corporate philosophy revolves around empowering its customers with the expertise, technology, and insights required for successful drug development and commercialization. Through its comprehensive range of services, Syneos Health is dedicated to driving clinical innovation, increasing efficiency, and ultimately improving patient lives.

Syneos Health Inc primarily operates in numerous countries and regions around the world. With a global presence, the company offers its services in North America, Europe, Asia-Pacific, and other key markets. Syneos Health Inc has established a strong foothold in the United States, where it is headquartered, and has expanded its reach across various European countries such as the United Kingdom, Germany, France, and Switzerland. Additionally, the company has a significant presence in Asia-Pacific countries like Japan, China, India, and Australia. Through its extensive geographical coverage, Syneos Health Inc demonstrates its commitment to serving clients and conducting clinical trials on a global scale.

Syneos Health Inc has achieved several significant milestones in its journey. One remarkable milestone was the merger of INC Research and inVentiv Health in 2017, creating Syneos Health Inc. This strategic combination allowed the company to offer end-to-end solutions to clients in the biopharmaceutical industry. Additionally, Syneos Health Inc became the first fully-integrated biopharmaceutical solutions organization, delivering innovative and efficient strategies for clinical development and commercialization. Furthermore, the company has expanded its global footprint by establishing a strong presence in over 40 countries worldwide. These achievements demonstrate Syneos Health Inc's commitment to providing comprehensive services and driving growth and success in the biopharmaceutical sector.

Syneos Health Inc is a leading global contract research organization (CRO) that provides integrated clinical and commercial solutions to the biopharmaceutical industry. The company was formed in 2017 through the merger of inVentiv Health and INC Research, both renowned industry players. Syneos Health has a rich history of excellence and innovation in delivering end-to-end services and expertise across the drug development and commercialization continuum. With a team of over 25,000 professionals worldwide, Syneos Health is dedicated to improving healthcare by helping customers accelerate the development and delivery of therapies and treatments.

The main competitors of Syneos Health Inc in the market include IQVIA Holdings Inc, PRA Health Sciences, Inc, and Icon Plc.

Syneos Health Inc is primarily active in the healthcare and pharmaceutical industries.

Syneos Health Inc operates as a leading global contract research organization (CRO) that provides integrated solutions to the pharmaceutical and biotechnology industries. The company offers a comprehensive range of services, including clinical development, commercialization, and consulting, aimed at accelerating the delivery of innovative therapies to patients. Syneos Health's business model focuses on leveraging its expertise, technology, and extensive network of resources to support clients in bringing new drugs and treatments to market efficiently. By combining clinical and commercial insights, the company aims to streamline the drug development process and improve the overall success rate for its clients. Syneos Health Inc is committed to revolutionizing the clinical research industry and advancing healthcare outcomes globally.

Syneos Health의 P/E 비율은 10.46입니다.

Syneos Health의 P/S 비율은 0.83입니다.

Syneos Health에 대한 AlleAktien 품질 점수는 4/10입니다.

예상되는 Syneos Health 매출은 5.37 조. USD입니다.

예상되는 Syneos Health 이익은 425.34 백만 USD입니다.

Syneos Health Inc is a company that specializes in supporting biotechnology and pharmaceutical companies in the development and marketing of products. The company's business model is based on four main areas: Clinical Solutions, Commercial Solutions, Consulting and Insights, and Medical Communications.

Syneos Health은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Syneos Health의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Syneos Health의 ISIN은 US87166B1026입니다.

Syneos Health의 WKN은 A2JBKW입니다.

Syneos Health의 티커는 SYNH입니다.

지난 12개월 동안 Syneos Health은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Syneos Health은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Syneos Health의 현재 배당 수익률은 입니다.

Syneos Health은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Syneos Health은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Syneos Health은 '건강' 섹터에 속합니다.

Syneos Health의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Syneos Health는 0 USD를 배당금으로 지급했습니다.

Syneos Health의 배당금은 USD에 지급됩니다.